D. Arachchillage

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.

H. Cohen, A. O’Keeffe, I. Mackie, 2018, Thrombosis research.

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.

S. Kitchen, R. Maclean, J. V. van Veen, 2016, Thrombosis research.

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply

S. Middeldorp, H. Cohen, J. Beyer-Westendorf, 2017, Journal of thrombosis and haemostasis : JTH.

Choosing and using non‐steroidal anti‐inflammatory drugs in haemophilia

M. Makris, D. Arachchillage, D. Arachchillage, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

H. Cohen, S. Machin, I. Mackie, 2014, Journal of thrombosis and haemostasis : JTH.

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH

S. Middeldorp, H. Cohen, J. Beyer-Westendorf, 2016, Journal of thrombosis and haemostasis : JTH.

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.

R. Reynolds, D. Arachchillage, T. Devey, 2016, Thrombosis research.